Insulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapy

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Scandinavian Journal of Rheumatology

• Publication date

  2007-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/03009740601179605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long‐term infliximab therapy

  2006cited by this paper
• Risk factors for the development of rheumatoid arthritis

  2006cited by this paper
• Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro.

  2005cited by this paper
• Cardiovascular death in rheumatoid arthritis: a population-based study.

  2005cited by this paper
• Effects of exercise and diet on chronic disease.

  2005cited by this paper
• P025 - TNF-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of AS160 phosphorylation

  2005cited by this paper
• The anti-inflammatory effect of exercise.

  2005cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.

  2005cited by this paper
• Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt.

  2005cited by this paper
• Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

  2005cited by this paper
• Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation.

  2005cited by this paper
• Interleukin-6 depletion selectively improves hepatic insulin action in obesity.

  2005cited by this paper
• Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB*

  2004cited by this paper
• Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness

  2004cited by this paper
• Use and abuse of HOMA modeling.

  2004cited by this paper
• Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo.

  2004cited by this paper
• Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial.

  2004cited by this paper
• Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes.

  2004cited by this paper
• Vascular viewpoint

  2004cited by this paper
• Inflammation: the link between insulin resistance, obesity and diabetes.

  2004cited by this paper
• Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis

  2004influential reference
• Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction.

  2004cited by this paper
• Acute interleukin‐6 administration does not impair muscle glucose uptake or whole‐body glucose disposal in healthy humans

  2003cited by this paper
• Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.

  2003cited by this paper
• Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone.

  2003cited by this paper
• New Therapies for Rheumatoid Arthritis.

  2003cited by this paper
• Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects*

  2003cited by this paper
• Suppressor of Cytokine Signaling-3 (SOCS-3), a Potential Mediator of Interleukin-6-dependent Insulin Resistance in Hepatocytes*

  2003cited by this paper
• Interleukin-6 induces cellular insulin resistance in hepatocytes.

  2002cited by this paper
• Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

  2002cited by this paper
• Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro.

  2002cited by this paper
• Interleukin-6-deficient mice develop mature-onset obesity

  2002cited by this paper
• Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus

  2001cited by this paper
• No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients.

  2000cited by this paper
• A tale of two diseases: atherosclerosis and rheumatoid arthritis.

  1999cited by this paper
• Comorbidity in arthritis.

  1999cited by this paper
• Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.

  1998cited by this paper
• Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon.

  1997cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.

  1997cited by this paper
• Protection from obesity-induced insulin resistance in mice lacking TNF-α function

  1997cited by this paper
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

  1997cited by this paper
• Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM

  1996cited by this paper
• The expression of TNF alpha by human muscle. Relationship to insulin resistance.

  1996cited by this paper
• Interleukin-6 enhances glucose transport in 3T3-L1 adipocytes.

  1996cited by this paper
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.

  1995cited by this paper
• Role of Cytokines in Inducing Hyperlipidemia

  1992cited by this paper
• Evidence for peripheral impaired glucose handling in patients with connective tissue diseases.

  1991cited by this paper
• Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance.

  1988cited by this paper

• Exploring the shared gene signatures between rheumatoid arthritis and type 2 diabetes and their implication for drug repositioning on bioinformatics analysis.

  2026cites this paper
• An update on the role of inflammation in insulin resistance and islet β cell failure- A crosstalk between immune cells, adipose tissue, cytokines, and oxidative stress

  2025cites this paper
• Adipokines in obesity and metabolic-related-diseases.

  2023cites this paper
• Post-COVID-19 syndrome and insulin resistance 20 months after a mild COVID-19

  2023cites this paper
• Effects of Nut Consumption on Cardiovascular Risk Factors and Coronary Heart Diseases

  2022cites this paper
• Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis.

  2022cites this paper
• Polycationic PAMAM ameliorates obesity-associated chronic inflammation and focal adiposity.

  2022cites this paper
• Rheumatoid Arthritis Treatment Options and Type 2 Diabetes: Unravelling the Association

  2022cites this paper
• Association of Rheumatoid Arthritis with Diabetic Comorbidity: Correlating Accelerated Insulin Resistance to Inflammatory Responses in Patients

  2021cites this paper
• Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis

  2021cites this paper
• Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study

  2021cites this paper
• Insulin Signaling in Arthritis

  2021cites this paper
• Exercise tolls the bell for key mediators of low-grade inflammation in dysmetabolic conditions.

  2021cites this paper
• Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges

  2021cites this paper
• Recombinant Soluble TNF‐α Receptor Fusion Protein Therapy Reduces Insulin Resistance in Non‐Diabetic Active Rheumatoid Arthritis Patients

  2020influential citation
• Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

  2020cites this paper
• The Effects of Obesity, Chronic Stress, and Exercise on Pancreatic Health

  2019cites this paper
• Influence of biologics on carbohydrate metabolism and risk of diabetes

  2019cites this paper
• Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies

  2019cites this paper
• Identification and characterization of differentially expressed genes in Type 2 Diabetes using in silico approach

  2019cites this paper
• Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies

  2019cites this paper
• Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease

  2018cites this paper
• The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

  2018cites this paper
• Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn’s Disease and Individuals with Obesity Before and After Bariatric Surgery

  2018cites this paper
• Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study

  2018cites this paper
• Relationship Between Insulin Sensitivity and β-Cell Secretion in Nondiabetic Subjects with Rheumatoid Arthritis

  2018cites this paper
• Control of hyperglycemia in male mice by leflunomide: mechanisms of action.

  2018cites this paper
• Comorbidity in Rheumatic Diseases

  2017cites this paper
• Anti‐inflammatory effects of exercise: role in diabetes and cardiovascular disease

  2017cites this paper
• NF-&kgr;B1/IKK&egr; Gene Expression and Clinical Activity in Patients With Rheumatoid Arthritis

  2017cites this paper
• Angiopoietin‐like 4: A molecular link between insulin resistance and rheumatoid arthritis

  2017cites this paper
• A characterisation of low-grade inflammation and metabolic complications in HIV-infected patients.

  2016cites this paper
• Psoriasis comorbidities: complications and benefits of immunobiological treatment*

  2016cites this paper
• Which Factors are Predictive for Presence of Insulin Resistance in Patients with Rheumatoid Arthritis

  2016cites this paper
• Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study.

  2016cites this paper
• To Restore Health, “Do we Have to Go Back to the Future?” The Impact of a 4-Day Paleolithic Lifestyle Change on Human Metabolism – a Pilot Study.

  2016cites this paper
• Role of Traditional Risk Factors, Inflammation and DMARDs in Cardiovascular Diseases in Rheumatoid Arthritis and Management of Lipid Profile

  2016cites this paper
• Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?

  2016cites this paper
• D IABETES M ELLITUS AND R HEUMATOID A RTHRITIS : FACTS SUPPORTING THEIR POSSIBLE ASSOCIATION

  2016cites this paper
• Exercise as an anti-inflammatory therapy for rheumatic diseases—myokine regulation

  2015cites this paper
• Diabetes Mellitus and Metabolic Syndrome

  2015cites this paper
• Insulin Resistance in Rheumatoid Arthritis: Disease‐Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis

  2015cites this paper
• Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis

  2015cites this paper
• Effects of Tumour Necrosis Factor Antagonists on Insulin Sensitivity/Resistance in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

  2015influential citation
• Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease

  2015cites this paper
• SENSITIVITY AND GLUCOSE HOMEOSTASIS HAVE A BENEFICIAL ROLE IN INSULIN COUNTERPOINT: INTERLEUKIN-6 DOES NOT

  2015cites this paper
• Adipose tissue inflammation in glucose metabolism

  2014cites this paper
• Turning Off a Viral/Lipid Sensor Improves Type 2 Diabetes

  2014cites this paper
• Adipose Depots, Not Disease-related Factors, Account for Skeletal Muscle Insulin Sensitivity in Established and Treated Rheumatoid Arthritis

  2014cites this paper
• Monoclonal Antibodies in Phase 1 and 2 Studies for Immunological Disorders

  2014cites this paper
• Normal Adipose Tissue Biology: Adipocytokines and Inflammation

  2014cites this paper
• Carbohydrate metabolism disorders in patients with rheumatoid arthritis and ankylosing spondylitis – impact of treatment

  2014cites this paper
• Is Visceral Fat the Missing Link in the Relationship Between Inflammation and Insulin Resistance in RA?

  2014cites this paper
• Increased cardiovascular risk in patients with rheumatoid arthritis: an overview

  2014cites this paper
• Adipose Tissue Inflammation

  2014cites this paper
• Insulin Resistance in RA ? Is Visceral Fat the Missing Link in the Relationship Between Inflammation and

  2014cites this paper
• Inflammation during obesity is not all bad: evidence from animal and human studies.

  2013cites this paper
• Inflammation, Cytokines and Insulin Resistance: A Clinical Perspective

  2013cites this paper
• Chronic inflammation and low-dose glucocorticoid effects on glucose metabolism in premenopausal females with rheumatoid arthritis free of conventional metabolic risk factors.

  2013cites this paper
• Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.

  2013cites this paper
• Macrophages and islet inflammation in type 2 diabetes

  2013cites this paper
• Effect of Anti-TNF Therapy on Resistance to Insulin in Patients with Rheumatoid Arthritis

  2013cites this paper
• Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity.

  2013cites this paper
• Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.

  2013cites this paper
• Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus

  2013cites this paper
• Obesity, Inflammation, and Insulin Resistance

  2013cites this paper
• Targeting inflammation in the treatment of type 2 diabetes

  2013cites this paper
• Direct Effects of TNF-α on Local Fuel Metabolism and Cytokine Levels in the Placebo-Controlled, Bilaterally Infused Human Leg

  2013cites this paper
• Direct Effects of TNF-a on Local Fuel Metabolism and Cytokine Levels in the Placebo-Controlled, Bilaterally Infused Human Leg Increased Insulin Sensitivity, Increased Net Protein Breakdown, and Increased IL-6 Release

  2013cites this paper
• Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals

  2012influential citation
• Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects

  2012cites this paper
• Aspects on Inflammation and Cardiovascular Comorbidity in Rheumatoid Arthritis

  2012cites this paper
• Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti–tumor necrosis factor α therapy

  2012cites this paper
• Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus.

  2012cites this paper
• Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications

  2012cites this paper
• Immunomodulation at epithelial sites by obesity and metabolic disease

  2012cites this paper
• The outliers become a stampede as immunometabolism reaches a tipping point

  2012cites this paper
• Drug-Cytokine Interactions

  2011cites this paper
• Low-grade Chronic Inflammation and Vascular Damage in Patients with Rheumatoid Arthritis: Don’t Forget “Metabolic Inflammation”

  2011cites this paper
• Does Therapy With Anti–TNF-α Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?

  2011cites this paper
• Blocking interleukin‐1β in acute and chronic autoinflammatory diseases

  2011cites this paper
• Adipose tissue macrophages inhibit adipogenesis of mesenchymal precursor cells via wnt-5a in humans

  2011cites this paper
• Seropositivity is associated with insulin resistance in patients with early inflammatory polyarthritis: results from the Norfolk Arthritis Register (NOAR): an observational study

  2011cites this paper
• Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: Risk reduction in a chronic inflammatory disease

  2011cites this paper
• [Insulin resistance and rheumatoid arthritis].

  2011cites this paper
• Why do anti-inflammatory therapies fail to improve insulin sensitivity?

  2011cites this paper
• Changes in Glycated Hemoglobin after Initiation of Hydroxychloroquine or Methotrexate in Diabetic Patients with Rheumatologic Diseases

  2011cites this paper
• Type 2 diabetes as an inflammatory disease

  2011cites this paper
• Immunomodulation at epithelial sites by obesity and metabolic disease

  2011cites this paper
• Resistencia insulnica y artritis reumatoide

  2011cites this paper
• Insulin resistance and rheumatoid arthritis

  2011cites this paper
• Insulin resistance in rheumatoid arthritis: the impact of the anti‐TNF‐α therapy

  2010cites this paper
• Rheumatoid cachexia and cardiovascular disease

  2010cites this paper
• Insulin resistance in early untreated rheumatoid arthritis patients.

  2010cites this paper
• Role of Tumour Necrosis Factor Alpha (TNFa) in ischaemic and pharmacological postconditioning

  2010cites this paper
• Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.

  2010cites this paper
• Effects of Inhibition of Interleukin-6 Signalling on Insulin Sensitivity and Lipoprotein (A) Levels in Human Subjects with Rheumatoid Diseases

  2010cites this paper
• Inflammatory and Anti-Inflammatory Mediators Secreted by Adipose Tissue

  2009cites this paper
• Body composition and bone mineral density in rheumatoid arthritis : Influence of inflammation and treatment with glucocorticoids and TNF-blocking agents

  2009cites this paper
• Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients?

  2009cites this paper